About us

Michael Stevens is a growth-focused executive with 25+ years of experience in the healthcare industry, specializing in commercial strategy, marketing , and bringing disruptive technologies to market. He has built a career at the intersection of science, innovation, and execution—helping early-stage companies transform breakthrough ideas into scalable, commercially successful solutions.

Michael has led high-impact initiatives in the dental and biotech sectors, including the U.S. commercial launch and fundraising strategy for InnerView at Perimetrics and the emerging technology portfolio at Valkyrie BioScience. His expertise spans go-to-market development, national sales infrastructure, advisory board creation, M&A, capital strategy, and strategic partnerships.

Known for his ability to translate complex science into clear commercial value, Michael builds strong relationships with clinicians, investors, and industry leaders. He has collaborated with some of the most respected voices in dentistry and biotechnology to drive adoption, credibility, and market traction.

With a deep commitment to scientific integrity, operational excellence, and improving patient outcomes, Michael continues to focus on advancing ethical, data-driven solutions that elevate the standard of care across healthcare.

Dr. Douglas P. Hansen cofounded 3Dio (now Valkyrie BioSciences) in 2019 and served as President and CEO until September, 2025, when Michael Stevens came aboard.  He holds a Ph.D. in physics from BYU and an MS in Physics from UCLA.  From personal experience, he feels the most satisfying experience an entrepreneur can have is to see the customer’s passion for that new product that solves their problem for the first time.   

He is an innovation-focused executive with over 30 years of experience in bringing high-tech products and technologies to market, having had previous success in the international consumer electronics ecosystem and in long-term data storage.  He has broad experience in international business, building relationships with multiple major corporations in Europe and Asia; in technical business development, OEM marketing and sales,  in nano-scale and micro-scale device fabrication, testing, and evaluation; and in patents, business contracting, and corporate governance.  

Matthew J. Hunt Sr. is a dedicated sales and marketing professional with over 35 years of experience driving corporate initiatives and achieving sales targets for startups, turnarounds and fortune 500 organizations. 

He has been directly responsible for new product launches, from concept to launch, and sales team development in the global capital equipment medical device industry. He has a proven track record of expanding and strengthening market share, customer support, and long-term business relationships to drive corporate profitability. In his work, he employs successful strategies to accelerate adoption in disruptive technologies.

Matthew brings wide-ranging dental knowledge, including distribution and direct sales organizations throughout the globe. His previous corporations include BIOLASE, Henry Schein, DMD and New Image, serving in various executive roles, including Vice President of Sales and Marketing, Director of Exclusives, General Manager.

Sandy Porritt is a seasoned executive with more than 30 years of experience leading clinical strategy, innovation, and growth within the dental industry. As Vice President of Clinical Affairs, Sandy brings deep industry expertise, strategic leadership, and a proven ability to translate clinical insight into meaningful business outcomes. Highly respected among clinicians and industry stakeholders, she is recognized for her expertise in Key Opinion Leader (KOL) engagement and for building trusted, high-impact partnerships. Sandy is passionate about developing dynamic teams, mentoring leaders, and creating platforms that empower dental professionals while advancing organizational growth and innovation.

Brad has 16 years of experience in leading medical device product development and manufacturing. He has worked for various organizations including large companies doing high volume production to smaller companies manufacturing highly complex systems. During the COVID pandemic, he was chosen as the Director of Quality to scale a small company with direct impact to the treatment of respiratory care patients.

Dr Cates has 25 years of experience in medical image processing. His experience includes extensive consulting and hands on product leadership in medical device development for start-ups and large medical device companies. He is a well-published expert in machine learning in medicine and biomedical image processing.

Butch has over 25 years of experience in the dental and healthcare industries, beginning as a banker and spending the past 10+ years serving as a CFO. He has worked with dental organizations ranging from sole practitioners to DSOs and brings deep financial and operational expertise. He has enjoyed supporting emerging companies such as Valkyrie BioScience in bringing innovative products to market that help dentists deliver exceptional patient care. Butch holds a BS in Physics, summa cum laude, from Arizona State University and a joint MBA from Columbia University and UC Berkeley.